Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Arthritis, Rheumatoid × Radioimmunodetection × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large-Cell, Immunoblastic 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2 Lymphoma, B-Cell, Marginal Zone 2 Lymphoma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Burkitt Lymphoma 2 Spondylarthritis 1 Rectal Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Breast Neoplasms, Male 1 Breast Neoplasms 1 Arthritis, Rheumatoid 1

Interventions

Methotrexate 9 Etanercept 9 Adalimumab 9 Abatacept 5 tocilizumab 4 tofacitinib 3 olokizumab 3 golimumab 3 Rituximab 3 Tumor Necrosis Factor Inhibitors 2 RC-18 2 Nivolumab 2 Infliximab 2 Antirheumatic Agents 2 veltuzumab 1 upadacitinib 1 secukinumab 1 sarilumab 1 mavrilimumab 1 entecavir 1 baricitinib 1 andecaliximab 1 Vitamin D 1 Sulfasalazine 1 Specimen Handling 1 Saline Solution 1 Radioimmunodetection 1 Pharmaceutical Preparations 1 Lysine Acetyltransferase 5 1 Leflunomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01590966 2019-08-26

SCINTRA

University Hospital, Ghent

Phase 3 Completed

Arthritis, Rheumatoid, Spondylarthritis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡